LaFerla, Frank M.
University of California, Irvine
71 papers on CoChatORCID 0000-0003-2324-6911
Most cited papers
- Verified
Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
Castillo, E., Leon, J., Mazzei, G., Abolhassani, N., Haruyama, N., Saito, T., Saido, T., Hokama, M., Iwaki, T., Ohara, T., et al. (2017) · Scientific Reports
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 158
- Verified
Multiple events lead to dendritic spine loss in triple transgenic Alzheimer’s disease mice
Bittner, T., Fuhrmann, M., Burgold, S., Ochs, S. M., Hoffmann, N., Mitteregger, G., Kretzschmar, H., LaFerla, F. M., & Herms, J. (2010) · PLoS ONE
Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research
Cited by 149
- Verified
Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
Koike, M. A., Green, K. N., Blurton-Jones, M., & LaFerla, F. M. (2010) · The American Journal of Pathology
Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments
Cited by 130
- Verified
Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer’s disease
Guzmán-Ramos, K., Moreno-Castilla, P., Castro-Cruz, M., McGaugh, J. L., Martínez-Coria, H., LaFerla, F. M., & Bermúdez-Rattoni, F. (2012) · Learning & Memory
Alzheimer's disease research and treatmentsMemory and Neural Mechanisms
Cited by 127
- Verified
Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus
Prieto, G. A., Snigdha, S., Baglietto-Vargas, D., Smith, E. D., Berchtold, N. C., Tong, L., Ajami, D., LaFerla, F. M., Rebek, J., & Cotman, C. W. (2015) · Proceedings of the National Academy of Sciences
Neuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research
Cited by 126
- Verified
Soluble Aβ Promotes Wild-Type Tau Pathology In Vivo
Chabrier, M. A., Blurton-Jones, M., Agazaryan, A. A., Nerhus, J. L., Martinez-Coria, H., & LaFerla, F. M. (2012) · The Journal of Neuroscience
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 123
- Verified
Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
Nicholson, R. M., Kusne, Y., Nowak, L. A., LaFerla, F. M., Reiman, E. M., & Valla, J. (2010) · Brain Research
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 107
- Verified
ABCA7 frameshift deletion associated with Alzheimer disease in African Americans
Cukier, H. N., Kunkle, B. W., Vardarajan, B. N., Rolati, S., Hamilton-Nelson, K. L., Kohli, M. A., Whitehead, P. L., Dombroski, B. A., Van Booven, D., Lang, R., et al. (2016) · Neurology Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 100
- Verified
Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease
Chabrier, M. A., Cheng, D., Castello, N. A., Green, K. N., & LaFerla, F. M. (2014) · Neurobiology of Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 97
- Verified
Age-related accumulation of Reelin in amyloid-like deposits
Knuesel, I., Nyffeler, M., Mormède, C., Muhia, M., Meyer, U., Pietropaolo, S., Yee, B. K., Pryce, C. R., LaFerla, F. M., Marighetto, A., et al. (2009) · Neurobiology of Aging
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 94
- Verified
Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease
Parachikova, A., Green, K. N., Hendrix, C., & LaFerla, F. M. (2010) · PLoS ONE
Alzheimer's disease research and treatmentsMedicinal Plants and Neuroprotection
Cited by 87
- Verified
Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice
Blanchard, J., Wanka, L., Tung, Y.-C., Cárdenas-Aguayo, M. D. C., LaFerla, F. M., Iqbal, K., & Grundke-Iqbal, I. (2010) · Acta Neuropathologica
Alzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanisms
Cited by 85
- Verified
Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
Oka, S., Leon, J., Sakumi, K., Ide, T., Kang, D., LaFerla, F. M., & Nakabeppu, Y. (2016) · Scientific Reports
Alzheimer's disease research and treatmentsMitochondrial Function and Pathology
Cited by 78
- Verified
Amyloid β-Peptide: The Inside Story
Tseng, B., Kitazawa, M., & LaFerla, F. (2004) · Current Alzheimer Research
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 72
- Verified
Reduction of the immunostainable length of the hippocampal dentate granule cells’ primary cilia in 3xAD-transgenic mice producing human Aβ1-42 and tau
Chakravarthy, B., Gaudet, C., Ménard, M., Brown, L., Atkinson, T., LaFerla, F. M., Ito, S., Armato, U., Dal Prà, I., & Whitfield, J. (2012) · Biochemical and Biophysical Research Communications
Alzheimer's disease research and treatmentsGenetic and Kidney Cyst Diseases
Cited by 52
- Verified
MTH1 and OGG1 maintain a low level of 8-oxoguanine in Alzheimer’s brain, and prevent the progression of Alzheimer’s pathogenesis
Oka, S., Leon, J., Sakumi, K., Abolhassani, N., Sheng, Z., Tsuchimoto, D., LaFerla, F. M., & Nakabeppu, Y. (2021) · Scientific Reports
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 51
- Verified
Genetically Altering Aβ Distribution from the Brain to the Vasculature Ameliorates Tau Pathology
Oddo, S., Caccamo, A., Cheng, D., & LaFerla, F. M. (2009) · Brain Pathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 33
- Verified
Activation of Cell Cycle Proteins in Transgenic Mice in Response to Neuronal Loss but not Amyloid-β and Tau Pathology
Lopes, J. P., Blurton-Jones, M., Yamasaki, T. R., Agostinho, P., & LaFerla, F. M. (2009) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 32
- Verified
APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology
Tran, K. M., Kwang, N. E., Butler, C. A., Gomez-Arboledas, A., Kawauchi, S., Mar, C., Chao, D., Barahona, R. A., Da Cunha, C., Tsourmas, K. I., et al. (2025) · Molecular Neurodegeneration
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 28
- Verified
Amyloid-β predominant Alzheimer’s disease neuropathologic change
Kovacs, G. G., Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Forrest, S. L., Alzheimer's Disease Genetics Consortium, Bowen, J. D., Crane, P. K., Jarvik, G. P., et al. (2025) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 19
- Verified
In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology
Torso, M., Ridgway, G. R., Valotti, M., Hardingham, I., Chance, S. A., for the National Alzheimer’s Coordinating Center, Brewer, J., Lopez, O., Hyman, B., Grabowski, T., et al. (2023) · Alzheimer's Research & Therapy
Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications
Cited by 16
- Verified
Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias
EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 7
- Verified
5xFAD/Abi3S209F mice display distinct age‐dependent effects on amyloid beta pathology and microglia dynamics
Butler, C. A., O'Gara, K., Mendoza‐Arvilla, A., Milinkeviciute, G., Da Cunha, C., Kawauchi, S., Rezaie, N., Liang, H. Y., Thach, A., Wang, S., et al. (2024) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free